Heparan Sulfate Proteoglycans Are Involved in Opiate Receptor-Mediated Cell Migration

Biochemistry

Volumn 43, Issue 1, 2004, Pages 237-244

  Kaneider, Nicole C ^a   Dunzendorfer, Stefan ^a   Wiedermann, Christian J ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; CELLS; CONCENTRATION (PROCESS); IMMUNOLOGY; POLYPEPTIDES; SIGNALING;

IMMUNE SYSTEM; IMMUNOMODULATORY EFFECT;

BIOCHEMISTRY;

ANGIOTENSIN; BETA ENDORPHIN; DELTA OPIATE RECEPTOR ANTAGONIST; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DIMETHYLSPHINGOSINE; ENZYME INHIBITOR; HEPARIN LYASE; INTERLEUKIN 8; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR ANTAGONIST; N ACETYLGALACTOSAMINE 4 SULFATASE; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE RECEPTOR; PROTEOHEPARAN SULFATE; SODIUM CHLORATE; SOMATOSTATIN; SPHINGOSINE KINASE; SYNDECAN; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKOCYTE MIGRATION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL;

EID: 0347357930     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi035295i     Document Type: Article

References (65)

1. Ruff, M. R., Wahl, S. M., Mergenhagen, S., and Pert, C. B. (1985) Opiate receptor-mediated chemotaxis of human monocytes, Neuropeptides 5, 363-366.
2. Heagy, W., Laurance, M., Cohen, E., and Finberg, R. (1990) Neurohormones regulate T cell function, J. Exp. Med. 171, 1625-1633.
3. Van Epps, D. E., and Saland, L. (1984) β-Endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis, J. Immunol. 132, 3046-3053.
4. Szabo, I., Chen, X. H., Xin, L., Adler, M. W., Howard, O. M., Oppenheim, J. J., and Rogers, T. J. (2002) Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain, Proc. Natl. Acad. Sci. U.S.A. 99, 10276-10281.
5. Stefano, G. B., Leung, M. K., Zhao, X. H., and Scharrer, B. (1989) Evidence for the involvement of opioid neuropeptides in the adherence and migration of immunocompetent invertebrate hemocytes, Proc. Natl. Acad. Sci. U.S.A. 86, 626-630.
6. Stefano, G. B., Goumon, Y., Casares, F., Cadet, P., Fricchione, G. L., Rialas, C., Peter, D., Sonetti, D., Guarna, M., Welters, I. D., and Bianchi, E. (2000) Endogenous morphine, Trends Neurosci. 23, 436-442.
7. Rogers, T. J., Steele, A. D., Howard, O. M., and Oppenheim, J. J. (2000) Bidirectional heterologous desensitization of opioid and chemokine receptors, Ann. N.Y. Acad. Sci. 917, 19-28.
8. Esche, C., Makarenkova, V. P., Kost, N. V., Lotze, M. T., Zozulya, A. A., and Shurin, M. R. (1999) Murine dendritic cells express functional delta-type opioid receptors, Ann. N.Y. Acad. Sci. 885, 387-390.
9. Serhan, C. N., Fierro, I. M., Chiang, N., and Pouliot, M. (2001) Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4, J. Immunol. 166, 3650-3654.
10. Mollereau, C., Parmentier, M., Mailleux, P., Butour, J. L., Moisand, C., Chalon, P., Caput, D., Vassart, G., and Meunier, J. C. (1994) ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization, FEBS Lett. 341, 33-38.
11. Calvo, C. F., Cesselin, F., Gelman, M., and Glowinski, J. (2000) Identification of an opioid peptide secreted by rat embryonic mixed brain cells as a promoter of macrophage migration, Eur. J. Neurosci. 12, 2676-2684.
12. Zhang, L., and Rogers, T. J. (2000) κ-Opioid regulation of thymocyte IL-7 receptor and C-C chemokine receptor 2 expression, J. Immunol. 164, 5088-5093.
13. Chao, C. C., Hu, S., Shark, K. B., Sheng, W. S., Gekker, G., and Peterson, P. K. (1997) Activation of mu opioid receptors inhibits microglial cell chemotaxis, J. Pharmacol. Exp. Ther. 281, 998-1004.
14. Zagon, I. S., Sassani, J. W., and McLaughlin, P. J. (1995) Opioid growth factor modulates corneal epithelial outgrowth in tissue culture, Am. J. Physiol. 268, R942-R950.
15. Wiedermann, C. J., Schratzberger, P., and Kahler, C. M. (1994) Migration of neutrophils across endothelial monolayers is stimulated by treatment of the monolayers with β-endorphin, Brain, Behav., Immun. 8, 270-277.
16. Singhal, P. C., Sharma, P., Gibbons, N., Franki, N., Kapasi, A., and Wagner, J. D. (1997) Effect of morphine on renomedullary interstitial cell proliferation and matrix accumulation, Nephron 77, 225-234.
17. Liu, Y., Blackbourn, D. J., Chuang, L. F., Killam, K. F., Jr., and Chuang, R. Y. (1992) Effects of in vivo and in vitro administration of morphine sulfate upon rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis, J. Pharmacol. Exp. Ther. 263, 533-539.
18. Grimm, M. C., Ben Baruch, A., Taub, D. D., Howard, O. M., Resau, J. H., Wang, J. M., Ali, H., Richardson, R., Snyderman, R., and Oppenheim, J. J. (1998) Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization, J. Exp. Med. 188, 317-325.
19. Manfreda, S. E., Dunzendorfer, S., Schratzberger, P., Buratti, T., Reinisch, N., Kahler, C. M., List, W. F., and Wiedermann, C. J. (1998) The chemotaxis of human peripheral blood B lymphocytes by β-endorphin is reversible by naloxone, Anesth. Analg. 86, 670-672.
20. Simpkins, C. O., Dickey, C. A., and Fink, M. P. (1984) Human neutrophil migration is enhanced by beta-endorphin, Life Sci. 34, 2251-2255.
21. Marotti, T., and Haberstok, H. (1992) Naloxone is an inappropriate antagonist of met-enkephalin-modulated superoxide anion release, Brain, Behav., Immun. 6, 223-233.
22. Horvath, K., Graf, L., Walcz, E., Bodanszky, H., and Schuler, D. (1985) Naloxone antagonises effect of alpha-gliadin on leucocyte migration in patients with coeliac disease, Lancet 2, 184-185.
23. Pasotti, D., Mazzone, A., and Ricevuti, G. (1992) The nervous system and the immune system: the role of morphine and opioid peptides in the function of neutrophilic granulocytes, Minerva Med. 83, 433-438.
24. Marcoli, M., Ricevuti, G., Mazzone, A., Pasotti, D., Lecchini, S., and Frigo, G. M. (1989) A stereoselective blockade by naloxone of opioid and non-opioid-induced granulocyte activation, Int. J. Immunopharmacol. 11, 57-61.
25. Kaneider, N. C., Reinisch, C. M., Dunzendorfer, S., Romisch, J., and Wiederman, C. J. (2002) Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes, J. Cell Sci. 115, 227-236.
26. Kaneider, N. C., Egger, P., Dunzendorfer, S., and Wiedermann, C. J. (2001) Syndecan-4 as antithrombin receptor of human neutrophils, Biochem. Biophys. Res. Commun. 287, 42-46.
27. Echtermeyer, F., Streit, M., Wilcox-Adelman, S., Saoncella, S., Denhez, F., Detmar, M., and Goetinck, P. (2001) Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J. Clin. Invest. 107, R9-R14.
28. Bass, M. D., and Humphries, M. J. (2002) Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signalling, Biochem. J. 368, 1-15.
29. Martin-Kleiner, I. (2002) The effect of opioid agonists of delta-class DSLET, mu-class DAMGO, kappa-class U-69593 and an opioid antagonist, naloxone, on MTT activity of NALM-1 leukemic cells, Biomed. Pharmacother. 56, 458-462.
30. Dunzendorfer, S., Kaneider, N., Rabensteiner, A., Meierhofer, C., Reinisch, C., Romisch, J., and Wiedermann, C. J. (2001) Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III, Blood 97, 1079-1085.
31. Schratzberger, P., Reinisch, N., Prodinger, W. M., Kahler, C. M., Sitte, B. A., Bellmann, R., Fischer-Colbrie, R., Winkler, H., and Wiedermann, C. J. (1997) Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells, J. Immunol. 158, 3895-3901.
32. Patel, L., et al. (2001) Expression and functional analysis of chemokine receptors in human peripheral blood leukocyte populations, Cytokine 14, 27-36.
33. Cockwell, P., et al. (2002) Chemoattraction of T cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines, Nephrol., Dial., Transplant. 17, 734-744.
34. Pace, E., et al. (1999) Interleukin-8 induces lymphocyte chemotaxis into the pleural space. Role of pleural macrophages, Am. J. Respir. Crit. Care Med. 159, 1592-1599.
35. Schratzberger, P., Geiseler, A., Dunzendorfer, S., Reinisch, N., Kahler, C. M., and Wiedermann, C. J. (1998) Similar involvement of VIP receptor type I and type II in lymphocyte chemotaxis, J. Neuroimmunol. 87, 73-81.
36. Leonard, E. J., Skeel, A., Yoshimura, T., Noer, K., Kutvirt, S., and Van Epps, D. (1990) Leukocyte specificity and binding of human neutrophil attractant/activation protein-1, J. Immunol. 144, 1323-1330.
37. Schratzberger, P., Dunzendorfer, S., Reinisch, N., Kahler, C. M., and Wiedermann, C. J. (1997) Interleukin-8-induced human peripheral blood B-lymphocyte chemotaxis in vitro, Immunol. Lett. 58, 167-170.
38. Wiedermann, C. J., Reinisch, N., Niedermuhlbichler, M., and Braunsteiner, H. (1993) Inhibition of recombinant human growth hormone-induced and prolactin-induced activation of neutrophils by octreotide, Naunyn-Schmiedeberg's Arch. Pharmacol. 347, 336-341.
39. Goetzl, E. J., Klickstein, L. B., Watt, K. W., and Wintroub, B. U. (1980) The preferential human mononuclear leukocyte chemotactic activity of the substituent tetrapeptides of angiotensin II, Biochem. Biophys. Res. Commun. 97, 1097-1102.
40. Weinstock, J. V., Blum, A. M., and Kassab, J. T. (1987) Angiotensin II is chemotactic for a T-cell subset which can express migration inhibition factor activity in murine schistosomiasis mansoni, Cell. Immunol. 107, 180-187.
41. Evans, C. J., Keith, D. E., Jr., Morrison, H., Magendzo, K., and Edwards, R. H. (1992) Cloning of a delta opioid receptor by functional expression, Science 258, 1952-1955.
42. Hammond, M. E., Lapointe, G. R., Feucht, P. H., Hilt, S., Gallegos, C. A., Gordon, C. A., Giedlin, M. A., Mullenbach, G., and Tekamp-Olson, P. (1995) IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors, J. Immunol. 155, 1428-1433.
43. Baciu, P. C., and Goetinck, P. F. (1995) Protein kinase C regulates the recruitment of syndecan-4 into focal contacts, Mol. Biol. Cell 6, 1503-1513.
44. Mertens, G., Cassiman, J. J., Van den, B. H., Vermylen, J., and David, G. (1992) Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties, J. Biol. Chem. 267, 20435-20443.
45. Kaneider, N., Djanani, A., Fischer-Colbrie, R., and Wiedermann, C. (2002) Sphingosine kinase-dependent directional migration of leukocytes in response to phorbol ester, Biochem. Biophys. Res. Commun. 297, 806.
46. Olivera, A., and Spiegel, S. (2001) Sphingosine kinase: a mediator of vital cellular functions, Prostaglandins Other Lipid Mediators 64, 123-134.
47. Vaday, G. G., Franitza, S., Schor, H., Hecht, I., Brill, A., Cahalon, L., Hershkoviz, R., and Lider, O. (2001) Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix, J. Leukocyte Biol. 69, 885-892.
48. Csaba, G., Kovacs, P., and Pallinger, E. (2002) β-Endorphin in granulocytes, Cell Biol. Int. 26, 741-743.
49. Vindrola, O., Padros, M., Sterin-Prync, A., Ase, A., Finkielman, S., and Nahmod, V. (1990) Proenkephalin system in human polymorphonuclear cells. Production and release of a novel 1.0-kD peptide derived from synenkephalin, J. Clin. Invest. 86, 531-537.
50. Wang, D., Raehal, K. M., Bilsky, E. J., and Sadee, W. (2001) Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence, J. Neurochem. 77, 1590-1600.
51. Ventayol, P., Busquets, X., and Garcia-Sevilla, J. A. (1997) Modulation of immunoreactive protein kinase C-alpha and beta isoforms and G proteins by acute and chronic treatments with morphine and other opiate drugs in rat brain, Naunyn-Schmiedeberg's Arch. Pharmacol. 355, 491-500.
52. Sacerdote, P., Manfredi, B., Gaspani, L., and Panerai, A. E. (2000) The opioid antagonist naloxone induces a shift from type 2 to type 1 cytokine pattern in BALB/cJ mice, Blood 95, 2031-2036.
53. Wiedermann, C. J., Sacerdote, P., Propst, A., Propst, T., Judmaier, G., Kathrein, H., Vogel, W., and Panerai, A. E. (1994) Decreased beta-endorphin content in peripheral blood mononuclear leukocytes from patients with Crohn's disease, Brain, Behav., Immun. 8, 261-269.
54. Buratti, T., Schratzberger, P., Dunzendorfer, S., Manfreda, S. E., Pechlaner, C., Joannidis, M., Sacerdote, P., Panerai, A. E., and Wiedermann, C. J. (1998) Decreased levels of beta-endorphin in circulating mononuclear leukocytes from patients with acute myocardial infarction, Cardiology 90, 43-47.
55. Sacerdote, P., Breda, M., Barcellini, W., Meroni, P. L., and Panerai, A. E. (1991) Age-related changes of beta-endorphin and cholecystokinin in human and rat mononuclear cells, Peptides 12, 1353-1356.
56. Kuschert, G. S., Coulin, F., Power, C. A., Proudfoot, A. E., Hubbard, R. E., Hoogewerf, A. J., and Wells, T. N. (1999) Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses, Biochemistry 38, 12959-12968.
57. Hobson, J. P., Rosenfeldt, H. M., Barak, L. S., Olivera, A., Poulton, S., Caron, M. G., Milstien, S., and Spiegel, S. (2001) Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility, Science 291, 1800-1803.
58. Oh, E. S., Woods, A., and Couchman, J. R. (1997) Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C, J. Biol. Chem. 272, 8133-8136.
59. Yu, G., LeBrun, L., Gunay, N. S., Hoppensteadt, D., Walenga, J. M., Fareed, J., and Linhardt, R. J. (2000) Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site, Thromb. Res. 100, 549-556.
60. Yamashita, Y., Oritani, K., Miyoshi, E. K., Wall, R., Bernfield, M., and Kincade, P. W. (1999) Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes, J. Immunol. 162, 5940-5948.
61. Kveberg, L., Bryceson, Y., Inngjerdingen, M., Rolstad, B., and Maghazachi, A. A. (2002) Sphingosine 1-phosphate induces the chemotaxis of human natural killer cells. Role for heterotrimeric G proteins and phosphoinositide 3 kinases, Eur. J. Immunol. 32, 1856-1864.
62. Idzko, M., Panther, E., Corinti, S., Morelli, A., Ferrari, D., Herouy, Y., Dichmann, S., Mockenhaupt, M., Gebicke-Haerter, P., Di Virgilio, F., Girolomoni, G., and Norgauer, J. (2002) Sphingosine 1-phosphate induces chemotaxis of immature dendritic cells and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses, FASEB J. 16, 625-7.
63. Brandes, M. E., Mai, U. E., Ohura, K., and Wahl, S. M. (1991) Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta, J. Immunol. 147, 1600-1606.
64. Buehrer, B. M., and Bell, R. M. (1992) Inhibition of sphingosine kinase in vitro and in platelets. Implications for signal transduction pathways, J. Biol. Chem. 267, 3154-3159.
65. Yung, B. Y., Hsiao, T. F., Wei, L. L., and Hui, E. K. (1994) Sphinganine potentiation of dimethyl sulfoxide-induced granulocyte differentiation, increase of alkaline phosphatase activity and decrease of protein kinase C activity in a human leukemia cell line (HL-60), Biochem. Biophys. Res. Commun. 199, 888-896.